J van Krieken

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. pmc Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer
    I Songun
    Department of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Cancer 92:1767-72. 2005
  2. pmc Improvement of hospital care for patients with non-Hodgkin's lymphoma: protocol for a cluster randomized controlled trial (PEARL study)
    Jozette J C Stienen
    Scientific Institute for Quality of Healthcare IQ Healthcare, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen The Netherlands
    Implement Sci 8:77. 2013
  3. pmc Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
    Ingrid P Vogelaar
    Department of Human Genetics, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen, 6500HB, The Netherlands
    Hered Cancer Clin Pract 10:18. 2012
  4. pmc Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
    Leonie J M Mekenkamp
    Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    BMC Cancer 12:292. 2012
  5. doi Guideline on the requirements of external quality assessment programs in molecular pathology
    J Han van Krieken
    Department of Pathology 824, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands
    Virchows Arch 462:27-37. 2013
  6. ncbi [Precise staging of colon cancer is indeed useful]
    Han Van Krieken
    UMC St Radboud, afd Pathologie, Nijmegen, The Netherlands
    Ned Tijdschr Geneeskd 156:A4816. 2012
  7. pmc Improving calculation, interpretation and communication of familial colorectal cancer risk: Protocol for a randomized controlled trial
    Nicky Dekker
    Scientific Institute for Quality of Healthcare, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Implement Sci 5:6. 2010
  8. pmc Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles
    Elza C de Bruin
    Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
    BMC Genomics 6:142. 2005
  9. pmc Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice
    Agnes G S H van Rossum
    Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
    BMC Cancer 6:58. 2006
  10. ncbi [Isolated tumour cells: 'seek, and ye shall find']
    J van Krieken
    Universitair Medisch Centrum St Radboud, afd Pathologie, Nijmegen, The Netherlands
    Ned Tijdschr Geneeskd 155:B677. 2011

Collaborators

Detail Information

Publications25

  1. pmc Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer
    I Songun
    Department of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Cancer 92:1767-72. 2005
    ..Loss of Ep-CAM-expression identifies aggressive tumours especially in patients with stage I and II disease. This information may be helpful in selecting patients suitable for surgery or for additional treatment pre- or postoperatively...
  2. pmc Improvement of hospital care for patients with non-Hodgkin's lymphoma: protocol for a cluster randomized controlled trial (PEARL study)
    Jozette J C Stienen
    Scientific Institute for Quality of Healthcare IQ Healthcare, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen The Netherlands
    Implement Sci 8:77. 2013
    ..Subsequently, we will assess the effectiveness, feasibility and costs of the improvement strategies...
  3. pmc Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
    Ingrid P Vogelaar
    Department of Human Genetics, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen, 6500HB, The Netherlands
    Hered Cancer Clin Pract 10:18. 2012
    ..Future research should focus on identifying new genetic predisposing factors for all types of familial gastric cancer...
  4. pmc Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
    Leonie J M Mekenkamp
    Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    BMC Cancer 12:292. 2012
    ..We assessed the influence of modification of KRAS by gene copy number aberration (CNA) and microRNAs (miRNAs) in correlation to clinical outcome in mCRC patients treated with cetuximab in combination with chemotherapy and bevacizumab...
  5. doi Guideline on the requirements of external quality assessment programs in molecular pathology
    J Han van Krieken
    Department of Pathology 824, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands
    Virchows Arch 462:27-37. 2013
    ..It is the intention of this guideline to improve EQA for molecular pathology in order to provide more reliable molecular analyses as well as optimal information regarding patient selection for treatment...
  6. ncbi [Precise staging of colon cancer is indeed useful]
    Han Van Krieken
    UMC St Radboud, afd Pathologie, Nijmegen, The Netherlands
    Ned Tijdschr Geneeskd 156:A4816. 2012
    ..The relatively low disease-staging score in patients with colon cancer in more recent years could be explained by an increase in screening programmes. Dutch data support this explanation...
  7. pmc Improving calculation, interpretation and communication of familial colorectal cancer risk: Protocol for a randomized controlled trial
    Nicky Dekker
    Scientific Institute for Quality of Healthcare, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Implement Sci 5:6. 2010
    ..Our results may also be useful in improving healthcare in other diseases. TRIAL REGISTRATION: ClinicalTrials.gov NCT00929097...
  8. pmc Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles
    Elza C de Bruin
    Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
    BMC Genomics 6:142. 2005
    ....
  9. pmc Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice
    Agnes G S H van Rossum
    Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
    BMC Cancer 6:58. 2006
    ..To study the role of cortactin in mammary gland tumorigenesis, we examined mouse mammary tumor virus (MMTV)-cortactin transgenic mice and MMTV-cortactin/-MMTV-cyclin D1 bitransgenic mice...
  10. ncbi [Isolated tumour cells: 'seek, and ye shall find']
    J van Krieken
    Universitair Medisch Centrum St Radboud, afd Pathologie, Nijmegen, The Netherlands
    Ned Tijdschr Geneeskd 155:B677. 2011
    ..Whether these tumour cells are clinically relevant is not always sure...
  11. ncbi [Isolated tumour cells: 'seek, and ye shall find']
    J van Krieken
    Universitair Medisch Centrum St Radboud, afd Pathologie, Nijmegen, The Netherlands
    Ned Tijdschr Geneeskd 155:B677. 2011
    ..Whether these tumour cells are clinically relevant is not always sure...
  12. doi KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program
    J H J M van Krieken
    Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, 6500, HB, The Netherlands
    Virchows Arch 453:417-31. 2008
    ..We also present guideline recommendations and a proposal for a European quality assurance program to help ensure accuracy and proficiency in KRAS mutation testing across the European Union...
  13. ncbi Pathological quality assurance in gastro-intestinal cancer
    J H J M van Krieken
    Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Eur J Surg Oncol 31:675-80. 2005
    ..Own data are, especially, derived from the recently conducted clinical trial on pre-operative radiotherapy for rectal cancer and emphasize the importance of multidisciplinary approaches...